Jeffrey C. Pelletier, PhD
Chief Scientific Officer
Founder, Inventor & Adjunct Professor Northwestern University
Dr. Pelletier has over 35 years’ experience in the pharmaceutical and biotech industry. He has been involved in all stages of drug development and commercialization, including shepherded novel small molecules to various levels of commercialization in prostate cancer, epilepsy, melanoma, and neurodegeneration.
Ottavio Arancio, MD, PhD
Founder, Inventor & Professor at Columbia University
Dr. Arancio is an expert on events triggered by amyloid protein and tau. His studies revealed new links between synaptic dysfunction and AD. Based on these findings, he has identified new approaches to developing therapies aimed at improvement of cognitive function. Dr. Arancio has published over 200 peer reviewed reports and is an author of several patents covering matter and treatment paradigms.
- Frank Longo, MD, PhD, Chair, Neurology & Neuroscience, Stanford Univ Medical School
- Jeffrey Cummings, MD, ScD, Director, Cleveland Clinic Neurological Institute, Las Vegas
- D. Martin Watterson, Ph.D., Inventor & J.G. Searle Professor, Northwestern University